Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Epithalon Acetate vs MOTS-c
An educational, source-based comparison of Epithalon Acetate and MOTS-c — how each peptide works, what it's researched for, and what to know before going deeper.
An N-acetylated variant of Epitalon (Ala-Glu-Asp-Gly) designed to improve metabolic stability and oral bioavailability. Research suggests the same telomerase activation and circadian-modulating properties as the parent peptide.
- Telomerase activity and cellular senescence
- Melatonin rhythm regulation
- Age-related immune restoration
- • Preclinical data; limited human clinical trials.
- • Not FDA-approved.
A 16-amino-acid peptide encoded within the mitochondrial 12S rRNA gene. Research suggests it activates AMPK, enhances insulin sensitivity, and regulates nuclear gene expression in response to metabolic stress — positioning it as a candidate mitochondrial-nuclear signaling peptide.
- Insulin sensitivity
- Exercise capacity and mitochondrial biogenesis
- Age-related metabolic decline
- Obesity models
- • Early-stage research; no approved human therapeutic use.
- • Long-term effects unknown.
Epithalon Acetate vs MOTS-c — Key differences
- Class: Epithalon Acetate is classified as Longevity · Circadian, while MOTS-c is Mitochondrial · Metabolic.
- Primary research focus: Epithalon Acetate — telomerase activity and cellular senescence; MOTS-c — insulin sensitivity.
- Tag: Longevity vs Longevity.